ICLR – ICON Public Limited Company
ICLR — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.42
Margin Of Safety %
13
Put/Call OI Ratio
0.7
EPS Next Q Diff
0.48
EPS Last/This Y
7.67
EPS This/Next Y
1.28
Price
164.54
Target Price
187.6
Analyst Recom
1.95
Performance Q
Upside
-95.7%
Beta
1.2
Ticker: ICLR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | ICLR | 166.2 | 0.53 | 0.09 | 15114 |
| 2026-07-14 | ICLR | 168.04 | 0.53 | 0.05 | 15215 |
| 2026-07-15 | ICLR | 172.14 | 0.53 | 0.20 | 15212 |
| 2026-07-16 | ICLR | 169.92 | 0.53 | 1.88 | 15229 |
| 2026-07-17 | ICLR | 170.18 | 0.59 | 1.85 | 16632 |
| 2026-07-20 | ICLR | 166.15 | 0.64 | 0.00 | 7893 |
| 2026-07-21 | ICLR | 166.48 | 0.64 | 0.69 | 7901 |
| 2026-07-22 | ICLR | 167.4 | 0.65 | 0.12 | 8119 |
| 2026-07-23 | ICLR | 170.25 | 0.70 | 1.14 | 7879 |
| 2026-07-24 | ICLR | 165.61 | 0.70 | 2.00 | 7892 |
| 2026-07-27 | ICLR | 168.68 | 0.70 | 0.03 | 7898 |
| 2026-07-28 | ICLR | 179.93 | 0.58 | 1.94 | 8847 |
| 2026-07-29 | ICLR | 177.86 | 0.76 | 0.46 | 9898 |
| 2026-07-30 | ICLR | 165.9 | 0.64 | 1.80 | 11726 |
| 2026-07-31 | ICLR | 163.56 | 0.64 | 0.01 | 11952 |
| 2026-08-03 | ICLR | 158.41 | 0.64 | 0.39 | 12009 |
| 2026-08-04 | ICLR | 157.85 | 0.64 | 58.06 | 11871 |
| 2026-08-05 | ICLR | 163.39 | 0.71 | 0.18 | 12397 |
| 2026-08-06 | ICLR | 161.28 | 0.70 | 5.00 | 12481 |
| 2026-08-07 | ICLR | 164.65 | 0.70 | 999.99 | 12486 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | ICLR | 166.20 | -22.8 | 494.0 | 10.63 |
| 2026-07-14 | ICLR | 168.01 | -22.8 | 508.7 | 10.63 |
| 2026-07-15 | ICLR | 172.19 | -22.8 | 517.9 | 10.63 |
| 2026-07-16 | ICLR | 169.99 | -22.8 | 491.8 | 10.63 |
| 2026-07-17 | ICLR | 170.11 | -22.8 | 501.4 | 10.64 |
| 2026-07-20 | ICLR | 166.03 | -22.8 | 483.6 | 10.64 |
| 2026-07-21 | ICLR | 166.56 | -22.8 | 502.3 | 10.64 |
| 2026-07-22 | ICLR | 167.49 | -22.8 | 504.8 | 10.64 |
| 2026-07-23 | ICLR | 170.41 | -22.8 | 514.0 | 10.64 |
| 2026-07-24 | ICLR | 165.74 | -22.8 | 481.0 | 10.64 |
| 2026-07-27 | ICLR | 168.66 | -22.8 | 514.0 | 10.64 |
| 2026-07-28 | ICLR | 180.09 | -22.8 | 549.6 | 10.64 |
| 2026-07-29 | ICLR | 177.92 | -22.8 | 491.1 | 10.64 |
| 2026-07-30 | ICLR | 165.71 | -22.8 | 449.3 | 10.64 |
| 2026-07-31 | ICLR | 163.41 | -18.9 | 583.1 | 10.64 |
| 2026-08-03 | ICLR | 158.34 | -18.9 | 569.0 | 10.64 |
| 2026-08-04 | ICLR | 158.34 | -18.9 | 569.0 | 10.64 |
| 2026-08-05 | ICLR | 163.55 | -19.1 | 623.9 | 10.59 |
| 2026-08-06 | ICLR | 161.22 | -19.1 | 582.1 | 10.59 |
| 2026-08-07 | ICLR | 164.54 | -19.2 | 504.9 | 10.59 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | ICLR | 0.00 | 3.60 | 3.94 |
| 2026-07-14 | ICLR | 0.00 | 3.60 | 3.94 |
| 2026-07-15 | ICLR | 0.00 | 3.60 | 3.94 |
| 2026-07-16 | ICLR | 0.00 | 3.60 | 3.94 |
| 2026-07-17 | ICLR | 0.00 | 3.60 | 3.94 |
| 2026-07-20 | ICLR | 0.00 | 4.34 | 3.94 |
| 2026-07-21 | ICLR | 0.00 | 4.34 | 3.94 |
| 2026-07-22 | ICLR | 0.00 | 4.34 | 3.94 |
| 2026-07-23 | ICLR | 0.00 | 4.34 | 3.94 |
| 2026-07-24 | ICLR | 0.00 | 4.34 | 3.94 |
| 2026-07-27 | ICLR | 0.00 | 4.93 | 3.42 |
| 2026-07-28 | ICLR | 0.00 | 4.93 | 3.42 |
| 2026-07-29 | ICLR | 0.00 | 4.93 | 3.42 |
| 2026-07-30 | ICLR | 0.00 | 4.93 | 3.42 |
| 2026-07-31 | ICLR | 0.00 | 4.93 | 3.42 |
| 2026-08-03 | ICLR | 0.00 | 2.60 | 3.42 |
| 2026-08-04 | ICLR | 0.00 | 2.60 | 3.42 |
| 2026-08-06 | ICLR | 0.00 | 2.60 | 3.42 |
| 2026-08-07 | ICLR | 0.00 | 2.60 | 3.42 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.35
Avg. EPS Est. Current Quarter
2.67
Avg. EPS Est. Next Quarter
2.83
Insider Transactions
Institutional Transactions
2.6
Beta
1.2
Average Sales Estimate Current Quarter
2007
Average Sales Estimate Next Quarter
2012
Fair Value
186.46
Quality Score
53
Growth Score
76
Sentiment Score
43
Actual DrawDown %
52.7
Max Drawdown 5-Year %
-76.9
Target Price
187.6
P/E
298.62
Forward P/E
13.78
PEG
5.2
P/S
1.53
P/B
1.35
P/Free Cash Flow
14.2
EPS
0.55
Average EPS Est. Cur. Y
10.59
EPS Next Y. (Est.)
11.87
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
0.51
Relative Volume
0.37
Return on Equity vs Sector %
-26.9
Return on Equity vs Industry %
-11
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.05
EBIT Estimation
504.9
◆
ICLR
Healthcare
$164.51
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
50.7
Range 1M
34.4%
Sup Dist
3.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-15.4%
52W%
70.3%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+3.7% upside
Upside
+3.7%
Quality
53
MoS
13%
ICLR — P/E HistoricalDiagnostics & Research
ICON plcSector: Healthcare
Industry: Diagnostics & Research
Employees: 40200
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
ICLR
Latest News
—
Caricamento notizie per ICLR…
stock quote shares ICLR – ICON Public Limited Company Stock Price stock today
news today ICLR – ICON Public Limited Company stock forecast ,stock prediction 2023 2024 2025
marketwatch ICLR – ICON Public Limited Company yahoo finance google finance
stock history ICLR – ICON Public Limited Company invest stock market
stock prices ICLR premarket after hours
ticker ICLR fair value insiders trading